Skip to main content

and
  1. Article

    Open Access

    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

    The purpose of this study is to identify prognostic markers and treatment targets using a clinically certified sequencing panel in multiple myeloma. We performed targeted sequencing of 578 individuals with pla...

    S S Chavan, J He, R Tytarenko, S Deshpande, P Patel, M Bailey in Blood Cancer Journal (2017)